Clinical Trial: Safety and Efficacy of Left Nucleus Accumbens-Targeted Temporal Interference Stimulation in Patients with Obsessive-Compulsive Disorder (China)

Posted On: 2026-08-25

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Safety and Efficacy of Left Nucleus Accumbens-Targeted Temporal Interference Stimulation in Patients with Obsessive-Compulsive Disorder'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130718

Registration Time: 2026/08/24

Type: Interventional study

Primary Sponsor: The First Hospital of Hebei Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339674

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Safety and Efficacy of Left Nucleus Accumbens-Targeted Temporal Interference Stimulation in Patients with Obsessive-Compulsive Disorder (China)